[ad_1]
After constantly downplaying the effects of the new coronavirus, US President Donald Trump himself fell ill last week. He is said to have had symptoms such as a fever and cough, and was treated for several days at Walter Reed Military Hospital in Maryland before being discharged Monday night.
In a new video that was posted late on Wednesday. Donald Trump explains that he is now fully recovered and dedicates a large part of the video to pay tribute to the REGN-cov-2 drug, developed by the company Regeneron Pharmaceuticals.
– It was amazing, I felt good right away. I felt as good three days ago as now. So I just want to say that we have regenerated and are trying to get it approved on short notice. I’ve approved it, says Trump.
He ends the video encourage sick people to apply for the drug in the treatment of covid-19.
– If you are in the hospital and you feel bad, I think we can do it so that you get it and you get it free, and especially if you are older, we will admit you quickly. Soon we will have hundreds of thousands of doses ready.
– Will improve and quickly. This is something that was not even planned a few months ago.
The drug is described as “A cocktail of two monoclonal antibodies”. Ali Mirazimi, Professor in the Department of Laboratory Medicine at the Karolinska Institutet, explains:
– What you do when you use monoclonals is simply that you create antibodies yourself in test tubes. So it is against a small part of the virus, which is why they are called monoclonal, an antibody against a very specific part of the virus. You make those antibodies against different parts of the virus, you pick a couple and mix it up and then you call it a cocktail, it says and continues:
– Here they have taken the protein of the nail, the protein of the virus that sits on the surface, finds the cells and enters and takes over. The idea is that if you block that protein, the virus can’t bind to cells and then inactivate it.
RAIN-cov-2 is not a miracle curehe says, but that in theory it can have the desired effect. But for the monoclonal antibodies to bind to the virus and ensure that it does not spread, treatment must be started at the right time.
– Many of the patients who are sick have already passed that stage. You have to treat patients very early to be able to see an effect and with it it may have worked because they came too early. With a fever, for example, you don’t go to the hospital on the first day, but go after a week when it gets worse, and then it’s too late to come in with these medications.
Before seeing the result of Extensive clinical trials cannot begin to recommend the use of the drug to the public, according to Ali Mirazimi.
– The same thing happens with vaccines, we are waiting for phase three, otherwise it can only be said that they are promising. But it is a publicly traded company that is behind the drug, so there is always a financial gain there.
Read more:
Here’s how Trump has mitigated risks during the pandemic
[ad_2]
